Free Trial
OTCMKTS:SUWN

Sunwin Stevia International (SUWN) Stock Price, News & Analysis

$0.0001 0.00 (0.00%)
As of 04/22/2025 12:11 PM Eastern

About Sunwin Stevia International Stock (OTCMKTS:SUWN)

Key Stats

Today's Range
$0.0001
$0.0001
50-Day Range
N/A
52-Week Range
$0.0001
$0.0003
Volume
30,000 shs
Average Volume
7,100 shs
Market Capitalization
$19,963.00
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Sunwin Stevia International, Inc. produces and sells natural sweeteners and other pharmaceutical products primarily in the People's Republic of China. It operates through two segments, Stevioside; and Corporate and Other Pharmaceutical. The company produces and sells various steviol glycosides with rebaudioside A and stevioside as the principal components. It offers Steviosin, a low calorie stevia extract for medicinal use; and OnlySweet, a zero calorie, tabletop sweetener to food and drug manufacturers, and ingredient distributor foreign trade companies. The company also produces and sells Metformin, a medication for the treatment of type 2 diabetes. Sunwin Stevia International, Inc. is based in Qufu, China.

Receive SUWN Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Sunwin Stevia International and its competitors with MarketBeat's FREE daily newsletter.

SUWN Stock News Headlines

10 Best Stevia Sweetners
Sunwin Stevia International Inc.
See More Headlines

SUWN Stock Analysis - Frequently Asked Questions

Sunwin Stevia International's stock was trading at $0.0001 at the beginning of the year. Since then, SUWN shares have increased by 0.0% and is now trading at $0.0001.
View the best growth stocks for 2025 here
.

Shares of SUWN stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Sunwin Stevia International investors own include Fulcrum Therapeutics (FULC), VIVUS (VVUS), Processa Pharmaceuticals (PCSA), Akero Therapeutics (AKRO), CymaBay Therapeutics (CBAY), Cumberland Pharmaceuticals (CPIX) and Entasis Therapeutics (ETTX).

Company Calendar

Today
4/24/2025
Fiscal Year End
4/30/2025

Industry, Sector and Symbol

Stock Exchange
OTCMKTS
Sector
Medical
Industry
Pharmaceutical preparations
Sub-Industry
Pharmaceutical Products
Current Symbol
OTCMKTS:SUWN
Employees
240
Year Founded
N/A

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
$35.26 million
Price / Cash Flow
N/A
Price / Book
N/A

Miscellaneous

Free Float
N/A
Market Cap
$19,963.00
Optionable
Not Optionable
Beta
0.03
7 Energy Stocks to Buy and Hold Forever Cover

With the proliferation of data centers and electric vehicles, the electric grid will only get more strained. Download this report to learn how energy stocks can play a role in your portfolio as the global demand for energy continues to grow.

Get This Free Report

This page (OTCMKTS:SUWN) was last updated on 4/25/2025 by MarketBeat.com Staff
From Our Partners